Authors:
MEINEKE I
DESEL H
KAHL R
KAHL GF
GUNDERTREMY U
Citation: I. Meineke et al., DETERMINATION OF 2-HYDROXYPHENYLACETIC ACID (2HPAA) IN URINE AFTER ORAL AND PARENTERAL ADMINISTRATION OF COUMARIN BY GAS-LIQUID-CHROMATOGRAPHY WITH FLAME-IONIZATION DETECTION, Journal of pharmaceutical and biomedical analysis, 17(3), 1998, pp. 487-492
Authors:
MEINEKE I
SCHREEB K
KRESS I
GUNDERTREMY U
Citation: I. Meineke et al., ROUTINE MEASUREMENT OF FLUOXETINE AND NORFLUOXETINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION IN PATIENTS UNDER CONCOMITANT TREATMENT WITH TRICYCLIC ANTIDEPRESSANTS, Therapeutic drug monitoring, 20(1), 1998, pp. 14-19
Authors:
MEINEKE I
SCHMIDT W
NOTTROTT M
SCHRODER T
HELLIGE G
GUNDERTREMY U
Citation: I. Meineke et al., MODELING OF NONLINEAR PHARMACOKINETICS IN SHEEP AFTER SHORT-TERM INFUSION OF CARDIOTOXIC DOSES OF IMIPRAMINE, Pharmacology & toxicology, 80(6), 1997, pp. 266-271
Citation: R. Hildebrandt et al., HYPOKALEMIA IN PREGNANT-WOMEN TREATED WITH THE BETA(2)-MIMETIC DRUG FENOTEROL - A CONCENTRATION AND TIME-DEPENDENT EFFECT, Journal of perinatal medicine, 25(2), 1997, pp. 173-179
Authors:
MEINEKE I
FELTKAMP H
HOGEMANN A
GUNDERTREMY U
Citation: I. Meineke et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CANDESARTAN AFTER ADMINISTRATION OF ITS PRO-DRUG CANDESARTAN CILEXETIL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION - A POPULATION ANALYSIS, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 221-228
Authors:
SCHREEB KH
FREUDENTHALER S
VORMFELDE SV
GUNDERTREMY U
GLEITER CH
Citation: Kh. Schreeb et al., COMPARATIVE BIOAVAILABILITY OF 2 VITAMIN-B1 PREPARATIONS - BENFOTIAMINE AND THIAMINE MONONITRATE, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 319-320
Authors:
GLEITER CH
BECKER T
BERGENER M
SCHREEB KH
FREUDENTHALER S
GUNDERTREMY U
Citation: Ch. Gleiter et al., FENOTEROL BUT NOT DOBUTAMINE INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 428-428
Authors:
GLEITER CH
HEER M
BECKER T
BRAU C
GERZER R
GUNDERTREMY U
Citation: Ch. Gleiter et al., IS ADENOSINE A MODULATOR OF RENAL ERYTHROPOIETIN PRODUCTION IN HUMANSEXPOSED TO HYPOBARIC HYPOXIA, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 442-442
Authors:
SCHREEB KH
FREUDENTHALER S
GLEITER CH
GUNDERTREMY U
Citation: Kh. Schreeb et al., RELATIVE BIOAVAILABILITY OF THE VITAMIN-B1 ANALOG BENFOTHIAM, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 475-475
Authors:
VORMFELDE SV
GLEITER CH
FREUDENTHALER S
MUCK W
SCHMAGE N
KUHLMANN J
GUNDERTREMY U
Citation: Sv. Vormfelde et al., PHARMACOKINETICS OF SINGLE-DOSE CERIVASTATIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION, Atherosclerosis, 130, 1997, pp. 127-127
Authors:
GLEITER CH
BECKER T
SCHREEB KH
FREUDENTHALER S
GUNDERTREMY U
Citation: Ch. Gleiter et al., FENOTEROL BUT NOT DOBUTAMINE INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Clinical pharmacology and therapeutics, 61(6), 1997, pp. 669-676
Authors:
KIETZMANN D
BOUILLON T
HAMM C
SCHWABE K
SCHENK H
GUNDERTREMY U
KETTLER D
Citation: D. Kietzmann et al., PHARMACODYNAMIC MODELING OF THE ANALGESIC EFFECTS OF PIRITRAMIDE IN POSTOPERATIVE-PATIENTS, Acta anaesthesiologica Scandinavica, 41(7), 1997, pp. 888-894
Citation: Ch. Gleiter et U. Gundertremy, GENDER DIFFERENCES IN PHARMACOKINETICS, European journal of drug metabolism and pharmacokinetics, 21(2), 1996, pp. 123-128
Authors:
GLEITER CH
FREUDENTHALER S
DELABAR U
ECKARDT KU
MUHLBAUER B
GUNDERTREMY U
OSSWALD H
Citation: Ch. Gleiter et al., ERYTHROPOIETIN PRODUCTION IN HEALTHY-VOLUNTEERS SUBJECTED TO CONTROLLED HEMORRHAGE - EVIDENCE AGAINST A MAJOR ROLE FOR ADENOSINE, British journal of clinical pharmacology, 42(6), 1996, pp. 729-735
Authors:
BOUILLON T
SCHIFFMANN H
BARTMUS D
GUNDERTREMY U
Citation: T. Bouillon et al., AMIODARONE IN A NEWBORN WITH VENTRICULAR-TACHYCARDIA AND AN INTRACARDIAC TUMOR - ADJUSTING THE DOSE ACCORDING TO AN INDIVIDUALIZED DOSING REGIMEN, Pediatric cardiology, 17(2), 1996, pp. 112-114
Authors:
BOUILLON T
MEINEKE I
PORT R
HILDEBRANDT R
GUNTHER K
GUNDERTREMY U
Citation: T. Bouillon et al., CONCENTRATION-EFFECT RELATIONSHIP OF THE POSITIVE CHRONOTROPIC AND HYPOKALEMIC EFFECTS OF FENOTEROL IN HEALTHY WOMEN OF CHILDBEARING AGE, European Journal of Clinical Pharmacology, 51(2), 1996, pp. 153-160
Authors:
GLEITER CH
SCHUG BS
HERMANN R
ELZE M
BLUME HH
GUNDERTREMY U
Citation: Ch. Gleiter et al., INFLUENCE OF FOOD-INTAKE ON THE BIOAVAILABILITY OF THIOCTIC ACID ENANTIOMERS, European Journal of Clinical Pharmacology, 50(6), 1996, pp. 513-514
Authors:
LOSER SV
MEYER J
FREUDENTHALER S
SATTLER M
DESEL C
MEINEKE I
GUNDERTREMY U
Citation: Sv. Loser et al., MORPHINE-6-O-BETA-D-GLUCURONIDE BUT NOT MORPHINE-3-O-BETA-GLUCURONIDEBINDS TO MU-SPECIFIC, DELTA-SPECIFIC AND KAPPA-SPECIFIC OPIOID BINDING-SITES IN CEREBRAL MEMBRANES, Naunyn-Schmiedeberg's archives of pharmacology, 354(2), 1996, pp. 192-197
Authors:
KRETZMANN D
BRIEDE I
BOUILLON T
GUNDERTREMY U
KETTLER D
Citation: D. Kretzmann et al., PHARMACOKINETICS OF PIRITRAMIDE AFTER AN INTRAVENOUS BOLUS IN SURGICAL PATIENTS, Acta anaesthesiologica Scandinavica, 40(8), 1996, pp. 898-903
Citation: U. Gundertremy, AGE AS AN INFLUENCING FACTOR OF THE DOSE- RESPONSE RELATIONSHIP, Zeitschrift fur Gerontologie und Geriatrie, 28(6), 1995, pp. 408-414
Authors:
HILDEBRANDT R
GUNDERTREMY U
RAEDSCH R
SIEG A
STIEHL A
Citation: R. Hildebrandt et al., BILIARY-EXCRETION OF MEZLOCILLIN IN PATIENTS WITH HEPATIC-DISEASE, International journal of clinical pharmacology and therapeutics, 33(7), 1995, pp. 384-387
Citation: I. Meineke et al., AN INEXPENSIVE AND SENSITIVE METHOD FOR THE DETERMINATION OF QUINIDINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLETDETECTION, Therapeutic drug monitoring, 17(1), 1995, pp. 75-78
Authors:
KIETZMANN D
FOTH H
GENG WP
RATHGEBER J
GUNDERTREMY U
KETTLER D
Citation: D. Kietzmann et al., TRANSPULMONARY DISPOSITION OF PRILOCAINE, MEPIVACAINE, AND BUPIVACAINE IN HUMANS IN THE COURSE OF EPIDURAL-ANESTHESIA, Acta anaesthesiologica Scandinavica, 39(7), 1995, pp. 885-890
Authors:
FROLICH JC
KIRCH WP
RIETBROCK N
ROOTS I
GUNDERTREMY U
Citation: Jc. Frolich et al., COMMENTS FROM CHAIRS OF INSTITUTES OF CLINICAL-PHARMACOLOGY IN GERMANY, Trends in pharmacological sciences, 15(11), 1994, pp. 410-410
Citation: Hj. Muller et U. Gundertremy, THE REGULATORY VIEW ON DRUG-DRUG INTERACTIONS, International journal of clinical pharmacology and therapeutics, 32(6), 1994, pp. 269-273